Business Other News 15 Jul 2020 Zydus begins human t ...

Zydus begins human trials for potential COVID-19 vaccine

REUTERS
Published Jul 15, 2020, 7:39 am IST
Updated Jul 15, 2020, 10:42 am IST
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India
Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine. (AP Photo)
 Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine. (AP Photo)

BENGALURU: Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

 

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

...
Location: India, Karnataka, Bengaluru




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT